Walleye Trading LLC Cerevel Therapeutics Holdings, Inc. Put Options Transaction History

Walleye Trading LLC

  • $46.7 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.96 - $42.75 $502,584 - $551,475
12,900 Added 106.61%
25,000 $1.02 Million
Q1 2024

May 15, 2024
BUY
$40.88 - $43.27 $20,440 - $21,635
500 Added 4.31%
12,100 $511,000
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $235,132 - $492,304
11,600 New
11,600 $491,000
Q1 2023

May 15, 2023
SELL
$22.82 - $35.32 $45,640 - $70,640
-2,000 Reduced 38.46%
3,200 $78,000
Q4 2022

Feb 14, 2023
BUY
$25.35 - $31.96 $131,820 - $166,192
5,200 New
5,200 $164,000

Others Institutions Holding CERE

# of Institutions
9
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email